NFKB1 and myeloid sarcoma: For example, in animal models of MS, triptolide and celastrol have been reported to reduce neuroinflammation and thereby improve behavioral deficits in model animals by inhibiting NF-kB activity (O'Brien et al., 2001; Wang et al., 2008).